Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice

By sjmartinez • August 10, 2023

Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Read SH, Jiang H, Chiang M, Lee E, Gupta R, Berry M, Kalil AC. Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice. Clin Infect Dis. 2023 Aug 9:ciad460. doi: 10.1093/cid/ciad460. Epub ahead of print. PMID: 37556727.

Tags: comparative effectiveness research, covid-19, immunocompromised, mortality, Publications, Pulmonary, Critical Care & Sleep Medicine, remdesivir, survival

Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis

Kishan AU, Sun Y, Parker CC, Sargos P, Sydes MR, Chabaud S, Brihoum M, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Shoag JE, Garcia[...]

Rebuilding the foundation: recommendations from the Summit to Revitalize Primary Care (Rev PC)

Summit to Revitalize Primary Care Writing Committee*; Jerant A, Kravitz RL, Fenton JJ, Lyles CR, Grumbach K, Henderson MC, Ritley D, Brandt M, Cohen D,[...]

Hepatocyte growth factor may contribute to male protection against pulmonary arterial hypertension

Medzikovic L, Ruffenach G, Dehghanitafti A, Wong B, Ryder A, Hatamnejad MR, Sun W, Esdin L, Eghbali J, Brownstein A, Razee A, Umar S, Hong[...]